EPB41L5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.473000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.430800E-01
Normal-vs-Stage2
8.326000E-01
Normal-vs-Stage3
4.851800E-01
Normal-vs-Stage4
2.833200E-01
Stage1-vs-Stage2
7.241700E-02
Stage1-vs-Stage3
6.042300E-02
Stage1-vs-Stage4
4.422200E-01
Stage2-vs-Stage3
2.077000E-01
Stage2-vs-Stage4
3.957000E-03
Stage3-vs-Stage4
6.654200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.697200E-01
Normal-vs-AfricanAmerican
5.703600E-01
Normal-vs-Asian
3.957600E-01
Caucasian-vs-AfricanAmerican
1.921210E-01
Caucasian-vs-Asian
7.312000E-02
AfricanAmerican-vs-Asian
5.050300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.874400E-01
Normal-vs-Female
8.912600E-01
Male-vs-Female
6.353000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.957600E-01
Normal-vs-Age(41-60Yrs)
6.898600E-01
Normal-vs-Age(61-80Yrs)
7.703400E-01
Normal-vs-Age(81-100Yrs)
2.164400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.500600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.492100E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.459100E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.054060E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.937400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.066400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.213800E-01
Normal-vs-Daily Drinker
4.035200E-01
Normal-vs-Weekly Drinker
7.016800E-01
Normal-vs-Occasional Drinker
7.239000E-01
Normal-vs-Social Drinker
9.746600E-01
Non Drinker-vs-Daily Drinker
2.060000E-01
Non Drinker-vs-Weekly Drinker
7.309000E-01
Non Drinker-vs-Occasional Drinker
1.998640E-01
Non Drinker-vs-Social Drinker
7.105400E-01
Daily Drinker-vs-Weekly Drinker
4.528600E-01
Daily Drinker-vs-Occasional Drinker
2.970200E-02
Daily Drinker-vs-Social Drinker
1.499350E-01
Weekly Drinker-vs-Occasional Drinker
1.956580E-01
Weekly Drinker-vs-Social Drinker
5.368800E-01
Occasional Drinker-vs-Social Drinker
4.510400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.056770E-01
Normal-vs-Grade 2
1.169650E-02
Normal-vs-Grade 3
1.021920E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.558800E-01
Grade 1-vs-Grade 3
8.736400E-01
Grade 1-vs-Grade 4
1.056770E-01
Grade 2-vs-Grade 3
1.018010E-01
Grade 2-vs-Grade 4
1.169650E-02
Grade 3-vs-Grade 4
1.021920E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.708400E-01
Normal-vs-NonDiabetic
9.471400E-01
Diabetic-vs-NonDiabetic
1.305810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.172000E-01
Normal-vs-NoPancreatitis
8.910000E-01
Pancreatitis-vs-NoPancreatitis
6.520400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.758200E-01
Normal-vs-N1
9.039200E-01
N0-vs-N1
8.106600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.749800E-01
Normal-vs-TP53-NonMutant
6.911800E-01
TP53-Mutant-vs-TP53-NonMutant
8.975200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
